Company intelligence / Profile preview

Klivo

São Paulo, São Paulo, Brazilklivoportal.de ↗

Ownership: Private
Development stage: Other

Overview

Klivo operates a digital health platform for continuous clinical monitoring and personalized care of patients with chronic diseases. The company reports improved patient engagement, increased chances of clinical improvement, and up to 65% reduction in medical costs. As of late 2021, it served over 21,000 people in Brazil. No traditional clinical trial results are reported as the company does not develop drugs.

Therapeutic areas: EndocrinologyCardiovascular
Modalities: DeviceNon-pharmacological therapy (digital health platform, remote monitoring)
Industry: Digital Health Medical Devices

Partnerships

Health plans/insurerspharmaceutical companieslaboratoriesFleury Group

Beyond the preview

Go deeper on Klivo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Klivo.

Explore the full profile